Evidence map›Paper›PMID 33205959›Full record

ArticleACS chemical neuroscience2020

Comparison of Elemental Anomalies Following Implantation of Different Cell Lines of Glioblastoma Multiforme in the Rat Brain: A Total Reflection X-ray Fluorescence Spectroscopy Study.

Karolina Planeta, Zuzanna Setkowicz, Natalia Janik-Olchawa, Katarzyna Matusiak, Damian Ryszawy, Agnieszka Drozdz, Krzysztof Janeczko, Beata Ostachowicz, Joanna Chwiej

Open access · hybridAbstract read
In one paragraph

Article in ACS chemical neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Karolina PlanetaAGH University of Science and Technology, Faculty of Physics and Applied Computer Science, Krakow 30-059, Poland.
Zuzanna SetkowiczJagiellonian University, Institute of Zoology and Biomedical Research, Krakow 31-007, Poland.
Natalia Janik-OlchawaAGH University of Science and Technology, Faculty of Physics and Applied Computer Science, Krakow 30-059, Poland.
Katarzyna MatusiakAGH University of Science and Technology, Faculty of Physics and Applied Computer Science, Krakow 30-059, Poland.ORCID 0000-0003-2211-8432
Damian RyszawyJagiellonian University, Faculty of Biochemistry, Biophysics, and Biotechnology, Krakow 31-007, Poland.
Agnieszka DrozdzAGH University of Science and Technology, Faculty of Physics and Applied Computer Science, Krakow 30-059, Poland.
Krzysztof JaneczkoJagiellonian University, Institute of Zoology and Biomedical Research, Krakow 31-007, Poland.
Beata OstachowiczAGH University of Science and Technology, Faculty of Physics and Applied Computer Science, Krakow 30-059, Poland.
Joanna ChwiejAGH University of Science and Technology, Faculty of Physics and Applied Computer Science, Krakow 30-059, Poland.ORCID 0000-0002-3792-7876
AGH University of Krakow · PLJagiellonian University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma multiforme (GBM) is a primary brain tumor with a very high degree of malignancy and is classified by WHO as a glioma IV. At present, the treatment of patients suffering from GBM is based on surgical resection of the tumor with maximal protection of surrounding tissues followed by radio- and pharmacological therapy using temozolomide as the most frequently recommended drug. This strategy, however, does not guarantee success and has devastating consequences. Testing of new substances or therapies having potential in the treatment of GBM as well as detection of their side effects cannot be done on humans. Animal models of the disease are usually used for these purposes, and one possibility is the implantation of human tumor cells into rodent brains. Such a solution was used in the present study the purpose of which was comparison of elemental anomalies appearing in the brain as a result of implantation of different glioblastoma cell lines. These were two commercially available cell lines (U87MG and T98G), as well as tumor cells taken directly from a patient diagnosed with GBM. Using total reflection X-ray fluorescence we determined the contents of P, S, K, Ca, Fe, Cu, Zn, and Se in implanted-left and intact-right brain hemispheres. The number of elemental anomalies registered for both hemispheres was positively correlated with the invasiveness of GBM cells and was the highest for animals subjected to U87MG cell implantation, which presented significant decrease of P, K, and Cu levels and an increase of Se concentration within the left hemisphere. The abnormality common for all three groups of animals subjected to glioma cell implantation was increased Fe level in the brain, which may result from higher blood supply or the presence of hemorrhaging regions. In the case of the intact hemisphere, elevated Fe concentration may also indicate higher neuronal activity caused by taking over some functions of the left hemisphere impaired as a result of tumor growth.

Indexed as

Brain NeoplasmsGlioblastomaAnimalsBrainCell Line, TumorHumansRatsSpectrometry, X-Ray EmissionTemozolomideTemozolomideanimal model of GBMbulk elemental analysis of brainGBMglioblastoma multiformeT98Gtotal reflection X-ray fluorescenceU87MG

Identifiers

PMID33205959
PMCPMC7747222
OpenAlexW3105101139

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.